LifeVantage Co. (NASDAQ:LFVN) Shares Bought by Victory Capital Management Inc.

Victory Capital Management Inc. grew its position in shares of LifeVantage Co. (NASDAQ:LFVN) by 46.2% in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 7,429 shares of the company’s stock after acquiring an additional 2,349 shares during the quarter. Victory Capital Management Inc. owned about 0.05% of LifeVantage worth $55,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. BNP Paribas Arbitrage SA boosted its holdings in shares of LifeVantage by 55.3% during the first quarter. BNP Paribas Arbitrage SA now owns 3,904 shares of the company’s stock valued at $37,000 after acquiring an additional 1,390 shares during the period. UBS Group AG boosted its holdings in shares of LifeVantage by 109.9% during the first quarter. UBS Group AG now owns 5,494 shares of the company’s stock valued at $51,000 after acquiring an additional 2,877 shares during the period. Bank of Montreal Can boosted its holdings in shares of LifeVantage by 309.5% during the first quarter. Bank of Montreal Can now owns 8,858 shares of the company’s stock valued at $81,000 after acquiring an additional 6,695 shares during the period. Algert Global LLC acquired a new position in shares of LifeVantage during the first quarter valued at $113,000. Finally, PDT Partners LLC boosted its holdings in shares of LifeVantage by 19.8% during the first quarter. PDT Partners LLC now owns 12,200 shares of the company’s stock valued at $114,000 after acquiring an additional 2,015 shares during the period. 39.45% of the stock is owned by institutional investors.

LFVN stock opened at $6.81 on Tuesday. The company has a market capitalization of $92.94 million, a P/E ratio of 7.57 and a beta of 1.42. The company has a 50-day simple moving average of $7.49 and a 200 day simple moving average of $8.04. LifeVantage Co. has a fifty-two week low of $6.50 and a fifty-two week high of $13.82.

LifeVantage (NASDAQ:LFVN) last posted its quarterly earnings data on Wednesday, August 18th. The company reported $0.31 earnings per share for the quarter, topping the consensus estimate of $0.20 by $0.11. LifeVantage had a net margin of 5.86% and a return on equity of 40.23%. On average, sell-side analysts expect that LifeVantage Co. will post 0.85 EPS for the current fiscal year.

LifeVantage Profile

LifeVantage Corp. engages in the identification, research, development and distribution of advanced nutraceutical dietary supplements and personal care products. The firm operates through the following geographical segments: Americas Region and Asia/Pacific and Europe Region. Its products include Protandim, LifeVantage Omega+ and ProBio, TrueScience and Petandim for dogs.

See Also: Dividend Kings

Want to see what other hedge funds are holding LFVN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LifeVantage Co. (NASDAQ:LFVN).

Institutional Ownership by Quarter for LifeVantage (NASDAQ:LFVN)

Receive News & Ratings for LifeVantage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeVantage and related companies with MarketBeat.com's FREE daily email newsletter.